Industry / Brazil
Is Your Investment Over-Hyping Emerging Markets?
July 2010 | Industry Trend AnalysisPharmaceutical companies are increasingly vocal about emerging markets, according to research conducted by BMI. The total number of mentions of 'emerging market' in Annual Reports, Forms 10K and Forms 20F for a selection of 15 large pharmaceutical companies has increased from 69 in 2006 to 239 in 2010.
To read the full article, please choose one of the following options:
Subcribers please log in




